• Completed the world's first in vivo Pulsed Field Ablation (PFA) procedure under real-time MRI guidance
• Demonstrates the flexibility and adaptability of Imricor's platform to serve the evolving needs of electrophysiologists
• Positions Imricor to deliver the benefits of real-time MRI guidance regardless of the energy source used for ablation

Imricor Medical Systems, Inc. (ASX: IMR) has announced the completion of the first Pulsed Field Ablation (PFA) ever performed under real-time MRI guidance in an iCMR lab. PFA has emerged as a promising new energy source for the treatment of atrial fibrillation, with important efficiency and safety advantages over conventional radiofrequency (RF) ablation. Imricor's technology enables real-time MRI-guided cardiac ablation, allowing physicians to perform procedures with real-time visualization of cardiac tissue and eliminating exposure to ionising radiation. The pre-clinical animal study procedure was performed using Imricor's second-generation Vision-MR™ Ablation Catheter at the company's iCMR Design Centre, validating the integration of PFA energy with real-time MRI visualisation. This achievement represents another global breakthrough for Imricor and an important step toward the company's long-term vision of performing all electrophysiology procedures under real-time MRI guidance, positioning Imricor to serve the evolving needs of electrophysiologists worldwide and to deliver the benefits of real-time MRI guidance regardless of the energy source used for ablating.

Imricor remains committed to enabling MRI-guided procedures regardless of energy source, ensuring that physicians and patients benefit from the unique advantages of MRI-guided electrophysiology. The company is pursuing the required regulatory approvals to place its key products on the market in the U.S. and other Middle East countries.